Alzheimer; News from the web:
The NOBLE Study, as it’s called, will examine whether the new drug, T-817MA, benefits people with mild to moderate Alzheimer’s disease. For more information about the clinical trial, call 855-LOU-RUVO (855-568-7886)
Read all about it HERE
Alzheimer; News from the web:
A new study has defined and established criteria for a new neurological disease closely resembling Alzheimer’s disease called primary age-related tauopathy (PART).
Read all about it HERE
Alzheimer; News from the web:
The University of Nebraska Medical Center is participating in a new, national, Alzheimer’s disease (AD) clinical research study evaluating the potential benefits of an investigational medicine when taken by people with mild-to-moderate AD who are already being treated with donepezil (Aricept).
Entitled NOBLE, the trial is evaluating an investigational drug, T-817MA, which may have the potential to modify the pace of the disease in those who are currently suffering with mild-to-moderate AD
Read all about it HERE
Alzheimer; News from the web:
Read all about it HERE
Alzheimer; News from the web:
A more in-depth report on the study we highlighted a few days ago where 10 patients showed remarkable progress and dementia reversal. Seems like lots of work and not a silver bullet but the results certainly need follow up and confirmation.
Read all about it HERE